AI data modeling and parsing
AI prepares databases, fields, relations, and an ER diagram from files or a scenario description. Low-confidence document parsing results are sent for human review.
Intelligent biopharma R&D management platform
R&D returns to scienceData becomes an intelligent asset
PhaseNext is built around a Data Agent designed for scientists. It understands R&D data, experimental context, and scientific workflows, helping teams turn fragmented data into research assets that can be analyzed, traced, and continuously applied.
Book a product consultationR&D data context
Connect data, decisions, approvals, and evidence.
PhaseNext organizes programs, batches, documents, samples, and external reports as connected R&D data.
Data
R&D records
Manage programs, batches, documents, samples, and external reports in workspaces.
Relations
Data relationships
Databases, properties, and relations preserve the structure and context between R&D records.
Governance
Approvals and evidence
Permissions, approvals, electronic signatures, and audit records govern official data.
Use
R&D data assets
Structured data supports queries, analysis, reporting, and audits.
Core capabilities
Data models and knowledge graphswith AI-assisted R&D management.
PhaseNext uses Schema-as-Data to keep R&D data models, relationships, and workflows on one platform.
Knowledge graph
Connect batches, materials, equipment, reports, and decisions for root-cause tracing and impact analysis.
Data governance
Submissions enter an approval flow and are written to official data after sign-off, with electronic signatures and field-level audit trails retained.
Platform architecture
Core design of PhaseNext.
The core design brings together data models, domain knowledge, a Data Agent, and regulatory compliance.
Schema-as-Data
Databases, fields, views, and relations are defined and adjusted in the user interface.
Biotech Vertical Pack
Domain templates, fields, and process states are packaged as installable, versioned packages with lifecycle records.
Data Agent
Understands R&D data and scientific context to help scientists organize, analyze, and apply research data.
ALCOA+ and 21 CFR Part 11
Complete access controls, electronic signatures, and audit trails ensure that R&D data fully conforms to ALCOA+ and supports 21 CFR Part 11.
Product consultation
Learn more about PhaseNext.
Colosscious provides PhaseNext product introductions and implementation assessments.
Contact Colosscious